Sanofi: Dupilumab adds to the interesting debate around cytokine mediators in severe asthma

BUY, Fair Value EUR92 (+8%)

News published on May Wednesday 22, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities